Previous 10 | Next 10 |
TAT Technologies (TATT) +37% after signing strategic agreement with Honeywell.Change Healthcare Inc. (CHNG) +35% as UnitedHealth to acquire the company for $25.75 in cash.DBV Technologies S.A. (DBVT) +19%.Aurora Cannabis (ACB) +17% on possible Georgia 'blue sweep'.HEXO (HEXO) +17%...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2020 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Co...
uniQure (QURE) -18% after the FDA clinical hold on its hemophilia B gene therapy program, including the pivotal, Phase 3 HOPE-B study.MingZhu Logistics Holdings Limited (YGMZ) -11%.CYREN (CYRN) -13%.Transocean (RIG) -11%.The9 (NCTY) -11%.DBV Technologies (DBVT) -11%.FibroG...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2020 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Code...
Nabriva Therapeutics NBRV -30% after priced $15M public offering.Aytu BioScience (AYTU) -25% on raising 'bought deal' offering to $25M.Immutep (IMMP) -24%.Professional Diversity Network (IPDN) -24%.SELLAS Life Sciences Group SLS -21% after announcing positiv...
SCWorx (WORX) +100%.Professional Diversity Network (IPDN) +25%.Apex Technology Acquisition (APXT) +20%.Genfit SA (GNFT) +18%.Xinyuan Real Estate (XIN) +17% on Q3 results.Rhythm Pharmaceuticals (RYTM) +16% as FDA OKs it's Imcivree for weight management in obese patients.Shi...
DBV Technologies (DBVT) announced that Hugh Sampson has decided to step down from his role as chief scientific officer, or CSO, at DBV, effective December 1, to return to his research program at the Jaffe Food Allergy Institute at Mount Sinai.While acting as CSO, Sampson continued his co...
DBV Technologies (DBVT) announces that Dr. Hugh Sampson has decided to step down from his role as Chief Scientific Officer ((CSO)), effective December 1, 2020, to return to his research program at the Jaffe Food Allergy Institute at Mount Sinai.Dr. Sampson will take on a new role as Scientifi...
Danaos (DAC) -19%.Renren (RENN) -11%.DBV Technologies (DBVT) -10% after announcing leadership changesSilvercorp Metals (SVM) -9% after TLP, LME, LMW and HPG mines in the Ying Mining District, Henan Province, and GC mine, Guangdong Province, have been certified as ...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2020 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN C...
News, Short Squeeze, Breakout and More Instantly...
DBV Technologies S.A. Company Name:
DBVT Stock Symbol:
NASDAQ Market:
DBV Technologies S.A. Website:
Châtillon, France, July 30, 2024 DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutic...
Châtillon, France, July 30, 2024 DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results VITESSE enrollment in peanut allergic 4-7-year-olds is on-track and recruitment is expecte...
Châtillon, France, July 29, 2024 DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, toda...